Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure.
暂无分享,去创建一个
[1] J. Henriksson,et al. Indirect Effect of Catecholamines on Development of Insulin Resistance in Skeletal Muscle From Diabetic Rats , 1989, Diabetes.
[2] G. Reaven. Role of Insulin Resistance in Human Disease , 1988, Diabetes.
[3] G. Paolisso,et al. Advantageous metabolic effects of pulsatile insulin delivery in noninsulin-dependent diabetic patients. , 1988, The Journal of clinical endocrinology and metabolism.
[4] R. Boston,et al. Hormonal effects of norepinephrine on acute glucose disposal in humans: a minimal model analysis. , 1988, Metabolism: clinical and experimental.
[5] R. DeFronzo. The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM , 1988, Diabetes.
[6] M. Packer,et al. Neurohormonal interactions and adaptations in congestive heart failure. , 1988, Circulation.
[7] G. Paolisso,et al. Primary role of glucagon release in the effect of beta-endorphin on glucose homeostasis in normal man. , 1987, Acta endocrinologica.
[8] H. Rosman,et al. Symptoms and tests of ventricular performance in the evaluation of chronic heart failure. , 1986, American heart journal.
[9] M. Bristow. The adrenergic nervous system in heart failure. , 1984, The New England journal of medicine.
[10] J. Cohn,et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.
[11] R. DeFronzo,et al. Effect of fatty acids on glucose production and utilization in man. , 1983, The Journal of clinical investigation.
[12] J. Cohn,et al. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. , 1982, The American journal of cardiology.
[13] J. A. Scarlett,et al. Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. , 1981, The Journal of clinical investigation.
[14] G. Corso,et al. Influence of epinephrine, norepinephrine, and isoproterenol on glucose homeostasis in normal man. , 1980, The Journal of clinical endocrinology and metabolism.
[15] R. Rizza,et al. Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man. , 1980, The Journal of clinical investigation.
[16] M. Wilén,et al. Functional capacity of patients with chronic left ventricular failure. Relationship of bicycle exercise performance to clinical and hemodynamic characterization. , 1979, The American journal of medicine.
[17] R. DeFronzo,et al. Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.
[18] D. Schade,et al. The Regulation of Plasma Ketone Body Concentration by Counter-Regulatory Hormones in Man: III. Effects of Norepinephrine in Normal Man , 1978, Diabetes.
[19] R. Eaton,et al. The Regulation of Plasma Ketone Body Concentration by Counter-regulatory Hormones in Man: II. Effects of Growth Hormone in Diabetic Man , 1978, Diabetes.
[20] P. Cryer,et al. Norepinephrine: hormone and neurotransmitter in man. , 1978, The American journal of physiology.
[21] J. A. Thomas,et al. Plasma norepinephrine in congestive heart failure. , 1978, The American journal of cardiology.
[22] M. da Prada,et al. Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range. , 1976, Life sciences.
[23] E. Braunwald,et al. CATECHOLAMINE EXCRETION AND CARDIAC STORES OF NOREPINEPHRINE IN CONGESTIVE HEART FAILURE. , 1965, The American journal of medicine.
[24] P. J. Randle,et al. The glucose-fatty-acid cycle. , 1963, Lancet.
[25] R. Steele,et al. INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT * , 1959, Annals of the New York Academy of Sciences.
[26] B. Billing,et al. The effect of adrenaline and noradrenaline on hepatic blood flow and splanchnic carbohydrate metabolism in man , 1951, The Journal of physiology.